Private company
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Limited company registered in Hong Kong, active since 2010. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersHong Kong, Hong Kong2
- Legal formPrivate company limited by shares2
- LEI549300PW6DL740UUHC852
- StatusActive2
- LEI statusIssued and current2
- Registered addressUnits 818-822, 8/F, 999077 Hong Kong, Hong Kong2
- Registered withBusiness Registration Office of the Inland Revenue Department, The Government of the Hong Kong Special Administrative Region, 527626242
Corporate structure
TYBOURNE CAPITAL MANAGEMENT (HK) LTD is part of a group headed by Tybourne Capital Management. 11 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of TYBOURNE CAPITAL MANAGEMENT (HK) LTD
- Viswanathan Krishnan Owns 75% or more of Tybourne Kesari, since 03/2012 (Form ADV)
- Tybourne Capital Management
- TYBOURNE CAPITAL MANAGEMENT (HK) LTD Hong Kong, Hong Kong
- Bicycle Therapeutics (United Kingdom) Stake · Cambridge, United Kingdom
- EXICURE, INC. Stake · Wilmington, Delaware, United States
- Forte Biosciences, Inc. Stake · San Diego, California, United States
- TPG Pace Beneficial Finance Corp. Stake · Forth Worth, Texas
- Zentalis Pharmaceuticals, Inc. Stake · San Diego, California
- TSOF II Japan Fund LP Fund · Hong Kong, Hong Kong
- Tybourne Strategic Opportunities Fund II LP Fund · Hong Kong, Hong Kong
- Tybourne Strategic Opportunities Fund III LP Fund · Central, Hong Kong
- Westbourne Long Short Master Fund Fund · Hong Kong, Hong Kong
- TYBOURNE CAPITAL MANAGEMENT (HK) LTD Hong Kong, Hong Kong
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (5 companies); owners and owned firms from Form ADV, the registration investment advisers file with the SEC. Each entity in the chart links to its source.
Investment adviser
TYBOURNE CAPITAL MANAGEMENT (HK) LTD is registered with the SEC as an investment adviser. This is what it reports on Form ADV, the registration every adviser files and keeps current.
- RegistrationSEC 802-76945, CRD 164723 IAPD record
Who owns it
Owners of 5% or more as the firm lists them (Schedule A), and the owners of those owners up the chain (Schedule B).
- TYBOURNE CAPITAL MANAGEMENTowns 75% or more, since 12/2011
- Viswanathan Krishnanowns 75% or more of TYBOURNE KESARI, since 03/2012
Timeline
- Jul 26, 2010Founded TYBOURNE CAPITAL MANAGEMENT (HK) LTD is founded2
Filings
21 filings to the SEC since October 2021: 21 other. The latest 20:
- Feb 23, 2026N-PX EDGAR
- Nov 6, 202513F-HR EDGAR
- Aug 14, 2025N-PX EDGAR
- Aug 1, 202513F-HR EDGAR
- May 15, 202513F-HR EDGAR
- Feb 14, 202513F-HR EDGAR
- Nov 14, 202413F-HR EDGAR
- Aug 19, 2024N-PX EDGAR
- Aug 14, 202413F-HR EDGAR
- May 15, 202413F-HR EDGAR
- Feb 14, 202413F-HR EDGAR
- Nov 14, 202313F-HR EDGAR
- Aug 14, 202313F-HR EDGAR
- May 15, 202313F-HR EDGAR
- Feb 14, 202313F-HR EDGAR
- Nov 14, 202213F-HR EDGAR
- Aug 15, 202213F-HR EDGAR
- May 4, 202213F-HR EDGAR
- Feb 25, 202213F-HR/A EDGAR
- Jan 26, 202213F-HR EDGAR
The 21 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
TYBOURNE CAPITAL MANAGEMENT (HK) LTD has told the SEC it owns more than 5% of 5 companies, latest first (Schedules 13D and 13G).
- Forte Biosciences, Inc.SCHEDULE 13G/A Feb 14, 2024 to Aug 4, 20254
- Zentalis Pharmaceuticals, Inc.SC 13G Feb 14, 2022 to Feb 14, 20235
- EXICURE, INC.SC 13D/A May 11, 20226
- Bicycle Therapeutics (United Kingdom)SC 13D/A Mar 14, 20227
- TPG Pace Beneficial Finance Corp.SC 13G/A Jan 3, 20228
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8